Supernus Pharmaceuticals
SUPN
#4185
Rank
HK$16.48 B
Marketcap
HK$298.50
Share price
0.05%
Change (1 day)
34.03%
Change (1 year)

EPS for Supernus Pharmaceuticals (SUPN)

EPS in 2023 (TTM): HK$6.18

According to Supernus Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is HK$6.15. In 2022 the company made an earnings per share (EPS) of HK$8.80 an increase over its 2021 EPS that were of HK$7.94.

EPS history for Supernus Pharmaceuticals from 2011 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$6.18-29.72%
2022HK$8.8010.78%
2021HK$7.94-57.68%
2020HK$18.7712.09%
2019HK$16.740.47%
2018HK$16.6789.38%
2017HK$8.80-38.59%
2016HK$14.33534.48%
2015HK$2.26-211.54%
2014-HK$2.02-91.1%
2013-HK$22.7439.46%
2012-HK$16.31-69.27%
2011-HK$53.07

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
HK$150.46 2,345.57%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$42.28 587.25%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$30.92 402.53%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$23.15 276.23%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$109.69 1,682.95%๐Ÿ‡บ๐Ÿ‡ธ USA